http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106957318-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3974068b7829f6e7f6fe642dcdf638fa
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2017-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba87e732ad4de34801a537d815545504
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc534a0ee00dbcd47e8635b7ee1e8122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9a221de1d205a1534466f84d52c9076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8e18f0e60cd35466602ffb7735f5425
publicationDate 2017-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106957318-A
titleOfInvention Fused polycyclic indoline compound, its preparation method, pharmaceutical composition and application
abstract The invention discloses a condensed polycyclic indoline compound, its preparation method, pharmaceutical composition and application. The compound provided by the present invention has obvious inhibitory effect on tumor cells Kyse-450, MDA-MB-231 and SKGT-4, and has significant biological activity to chloroquine-resistant Plasmodium falciparum dd2; at the same time, the preparation method of the present invention The reaction yield is high, the synthesis steps are short, the range of applicable substituents is wide, the operation is simple, and the industrial application prospect is expected to be realized.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110078749-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110078749-A
priorityDate 2016-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012052491-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103547579-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013153143-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104513254-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466266293
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467629709
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411792272
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163962396
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466167905
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465736077
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467944090
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148712604
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466457421
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467816100
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467746339
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466505466

Total number of triples: 40.